Silvia P. Neciosup
Instituto Nacional de Enfermedades Neoplásicas(PE)
Publications by Year
Research Areas
Breast Cancer Treatment Studies, Global Cancer Incidence and Screening, BRCA gene mutations in cancer, Advanced Breast Cancer Therapies, HER2/EGFR in Cancer Research
Most-Cited Works
- → 5th ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 5)(2020)1,319 cited
- → Combination of everolimus with trastuzumab plus paclitaxel as first-line treatment for patients with HER2-positive advanced breast cancer (BOLERO-1): a phase 3, randomised, double-blind, multicentre trial(2015)301 cited
- → 6th and 7th International consensus guidelines for the management of advanced breast cancer (ABC guidelines 6 and 7)(2024)166 cited
- → Breast Cancer Classification According to Immunohistochemistry Markers: Subtypes and Association With Clinicopathologic Variables in a Peruvian Hospital Database(2010)164 cited
- → In silico evaluation of DNA Damage Inducible Transcript 4 gene (DDIT4) as prognostic biomarker in several malignancies(2017)86 cited
- 進行性乳癌に対するESO-ESMO国際コンセンサスガイドライン第5版(ABC 5)(2020)
- → Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer Is Associated with Indigenous American Ancestry in Latin American Women(2020)54 cited
- → The impact of educational materials on compliance and persistence rates with adjuvant aromatase inhibitor treatment: First-year results from the Compliance of ARomatase Inhibitors AssessmenT In Daily practice through Educational approach (CARIATIDE) study(2014)54 cited
- → Immunotherapy in triple-negative breast cancer: A literature review and new advances(2022)50 cited
- → The implementation of the Plan Esperanza and response to the imPACT Review(2017)45 cited